Cell proliferation and apoptosis are typical hallmarks of
autosomal dominant polycystic kidney disease (
ADPKD) and cause the development of kidney
cysts that lead to
end-stage renal disease (
ESRD). Many factors, impaired by
polycystin complex loss of function, may promote these biological processes, including cAMP, mTOR, and EGFR signaling pathways. In addition,
microRNAs (miRs) may also regulate the
ADPKD related signaling network and their dysregulation contributes to
disease progression. However, the role of miRs in
ADPKD pathogenesis has not been fully understood, but also the function of p53 is quite obscure, especially its regulatory contribution on cell proliferation and apoptosis. Here, we describe for the first time that miR501-5p, upregulated in
ADPKD cells and tissues, induces the activation of mTOR
kinase by PTEN and TSC1 gene repression. The increased activity of mTOR
kinase enhances the expression of
E3 ubiquitin ligase MDM2 that in turn promotes p53 ubiquitination, leading to its degradation by
proteasome machinery in a network involving
p70S6K. Moreover, the overexpression of miR501-5p stimulates cell proliferation in kidney cells by the inhibition of p53 function in a mechanism driven by mTOR signaling. In fact, the downregulation of this miR as well as the pharmacological treatment with
proteasome and
mTOR inhibitors in
ADPKD cells reduces cell growth by the activation of apoptosis. Consequently, the stimulation of cell death in
ADPKD cells may occur through the inhibition of mTOR/MDM2 signaling and the restoring of p53 function. The data presented here confirm that the impaired mTOR signaling plays an important role in
ADPKD.